New HIV vaccine shows unprecedented success in preclinical study

Per Hacker News, a new HIV vaccine has shown unprecedented success in preclinical research. The preclinical phase tests a vaccine in cells and animal models before moving to human trials—a critical early milestone for any vaccine candidate.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton